Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 16 results.
User Information
Export Records
  1. 1.   Tumor-associated macrophage, angiogenesis and lymphangiogenesis markers predict prognosis of non-small cell lung cancer patients
  2. Hwang, Ilseon; Kim, Jeong Won; Ylaya, Kris; Chung, Eun Joo; Kitano, Haruhisa; Perry,Candice; Hanaoka, Jun; Fukuoka, Junya; Chung, Joon-Yong; Hewitt, Stephen M
  3. Journal of translational medicine. 2020, Nov 23; 18(1): 443.
  1. 2.   Vascular endothelial growth factor receptor 2 inhibition in-vivo affects tumor vasculature in a tumor type-dependent way and downregulates vascular endothelial growth factor receptor 2 protein without a prominent role for miR-296
  2. Langenkamp, E.; Zwiers, P. J.; Moorlag, H. E.; Leenders, W. P.; Croix, B. S.; Molema, G.
  3. Anti-Cancer Drugs. 2012, Feb; 23(2): 161-172.
  1. 3.   A novel lipoxygenase inhibitor Nordy attenuates malignant human glioma cell responses to chemotactic and growth stimulating factors
  2. Chen, J. H.; Yao, X. H.; Gong, W.; Hu, J.; Zhou, X. D.; Chen, K.; Liu, H.; Ping, Y. F.; Wang, J. M.; Bian, X. W.
  3. Journal of Neuro-Oncology. 2007, Sep; 84(3): 223-231.
  1. 4.   Preferential expression of chemokine receptor CXCR4 by highly malignant human gliomas and its association with poor patient survival
  2. Bian, X. W.; Yang, S. X.; Chen, L. H.; Ping, Y. F.; Zhou, X. D.; Wang, Q. L.; Jiang, X. F.; Gong, W. H.; Xiao, H. L.; Du, L. L.; Chen, Z. Q.; Zhao, W.; Shi, L. Q.; Wang, J. M.
  3. Neurosurgery. 2007, Sep; 61(3): 570-578.
  1. 5.   The anti-cancer compound Nordy inhibits CXCR4-mediated production of IL-8 and VEGF by malignant human glioma cells
  2. Ping, Y. F.; Yao, X. H.; Chen, J. H.; Liu, H.; Chen, D. L.; Zhou, X. D.; Wang, J. M.; Bian, X. W.
  3. Journal of Neuro-Oncology. 2007, Aug; 84(1): 21-29.
  1. 6.   Accelerated tumor formation in a fatless mouse with type 2 diabetes and inflammation
  2. Nunez, N. P.; Oh, W. J.; Rozenberg, J.; Perella, C.; Anver, M.; Barrett, J. C.; Perkins, S. N.; Berrigan, D.; Moitra, J.; Varticovski, L.; Hursting, S. D.; Vinson, C.
  3. Cancer Research. 2006, MAY 15; 66(10): 5469-5476.
  1. 7.   Increased angiogenic capabilities of endothelial cells from microvessels of malignant human gliomas
  2. Bian, X. W.; Jiang, X. F.; Chen, J. H.; Bai, J. S.; Dai, C.; Wang, Q. L.; Lu, J. Y.; Zhao, W.; Xin, R.; Liu, M. Y.; Shi, J. Q.; Wang, J. M.
  3. International Immunopharmacology. 2006, Jan; 6(1): 90-99.
  1. 8.   Adrenomedullin is a cross-talk molecule that regulates tumor and mast cell function during human carcinogenesis
  2. Zudaire, E.; Martinez, A.; Garayoa, M.; Pio, R.; Kaur, G.; Woolhiser, M. R.; Metcalfe, D. D.; Hook, W. A.; Siraganian, R. P.; Guise, T. A.; Chirgwin, J. M.; Cuttitta, F.
  3. American Journal of Pathology. 2006, JAN; 168(1): 280-291.
  1. 9.   Inhibition of pathologic retinal neovascularization by alpha-defensins
  2. Economopoulou, M.; Bdeir, K.; Cines, D. B.; Fogt, F.; Bdeir, Y.; Lubkowski, J.; Lu, W. Y.; Preissner, K. T.; Hammes, H. P.; Chavakis, T.
  3. Blood. 2005, DEC 1; 106(12): 3831-3838.
  1. 10.   Echinomycin, a small-molecule inhibitor of hypoxia-inducible factor-1 DNA-binding activity
  2. Kong, D. H.; Park, E. J.; Stephen, A. G.; Calvani, M.; Cardellina, J. H.; Monks, A.; Fisher, R. J.; Shoemaker, R. H.; Melillo, G.
  3. Cancer Research. 2005, OCT 1; 65(19): 9047-9055.
  1. 11.   Topotecan blocks hypoxia-inducible factor-1 alpha, and vascular endothelial growth factor expression induced by insulin-like growth factor-I in neuroblastoma cells
  2. Beppu, Y.; Nakamura, K.; Linehan, W. M.; Rapisarda, A.; Thiele, C. J.
  3. Cancer Research. 2005, JUN 1; 65(11): 4775-4781.
  1. 12.   Formylpeptide receptor FPR and the rapid growth of malignant human gliomas
  2. Zhou, Y.; Bian, X. W.; Le, Y. Y.; Gong, W. H.; Hu, J. Y.; Zhang, X.; Wang, L. H.; Iribarren, P.; Salcedo, R.; Howard, O. M. Z.; Farrar, W.; Wang, J. M.
  3. Journal of the National Cancer Institute. 2005, JUN 1; 97(11): 823-835.
  1. 13.   Protein kinase C alpha-mediated chemotaxis of neutrophils requires NF-kappa B activity but is independent of TNF alpha signaling in mouse skin in vivo
  2. Cataisson, C.; Pearson, A. J.; Torgerson, S.; Nedospasov, S. A.; Yuspa, S. H.
  3. Journal of Immunology. 2005, FEB 1; 174(3): 1686-1692.
  1. 14.   Lymphatic dysfunction in transgenic mice expressing KSHV k-cyclin under the control of the VEGFR-3 promoter
  2. Sugaya, M.; Watanabe, T.; Yang, A.; Starost, M. F.; Kobayashi, H.; Atkins, A. M.; Borris, D. L.; Hanan, E. A.; Schimel, D.; Bryant, M. A.; Roberts, N.; Skobe, M.; Staskus, K. A.; Kaldis, P.; Blauvelt, A.
  3. Blood. 2005 105(6): 2356-2363.
  1. 15.   Angiopoietins 3 and 4: Diverging gene counterparts in mice and humans
  2. Valenzuela, D. M.; Griffiths, J. A.; Rojas, J.; Aldrich, T. H.; Jones, P. F.; Zhou, H.; McClain, J.; Copeland, N. G.; Gilbert, D. J.; Jenkins, N. A.; Huang, T.; Papadopoulos, N.; Maisonpierre, P. C.; Davis, S.; Yancopoulos, G. D.
  3. Proceedings of the National Academy of Sciences of the United States of America. 1999 96(5): 1904-1909.
  1. 16.   Regulation of Vascular Endothelial Growth Factor (Vegf) Expression Is Mediated By Internal Initiation of Translation and Alternative Initiation of Transcription
  2. Akiri, G.; Nahari, D.; Finkelstein, Y.; Le, S. Y.; Elroystein, O.; Levi, B. Z.
  3. Oncogene. 1998 17(2): 227-236.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel